Advertisement
Screener

agilon health, inc. (AGL) Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid

2.9 / 5 stars · 23/39 Roast Me

agilon health, inc. Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid

agilon health, inc. (AGL) reported Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid of $2.47 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Financing Activities

us-gaap:PaymentsForLossesAndLossAdjustmentExpense · last filed 2026-08-05

  • agilon health, inc. liability for unpaid claims and claims adjustment expense, claims paid for the quarter ending 2026-06-30 was $1.32B, a 13.38% decline year-over-year.
  • agilon health, inc. liability for unpaid claims and claims adjustment expense, claims paid for the quarter ending 2026-03-31 was $1.15B, a 6.00% decline year-over-year.
  • agilon health, inc. liability for unpaid claims and claims adjustment expense, claims paid for the quarter ending 2025-12-31 was $1.78B, a 0.16% decline year-over-year.
  • agilon health, inc. liability for unpaid claims and claims adjustment expense, claims paid for the quarter ending 2025-09-30 was $1.47B, a 4.37% increase year-over-year.
  • agilon health, inc. liability for unpaid claims and claims adjustment expense, claims paid for fiscal 2025 was $6.00B, a 6.27% increase from fiscal 2024.
  • agilon health, inc. liability for unpaid claims and claims adjustment expense, claims paid for fiscal 2024 was $5.65B, a 44.97% increase from fiscal 2023.
  • agilon health, inc. liability for unpaid claims and claims adjustment expense, claims paid for fiscal 2023 was $3.90B, a 69.44% increase from fiscal 2022.
  • agilon health, inc. liability for unpaid claims and claims adjustment expense, claims paid for fiscal 2022 was $2.30B, a 46.26% increase from fiscal 2021.
Period endLiability for Unpaid Claims and Claims Adjustment Expense, Claims Paid 3 monthLiability for Unpaid Claims and Claims Adjustment Expense, Claims Paid 6 monthLiability for Unpaid Claims and Claims Adjustment Expense, Claims Paid 9 monthLiability for Unpaid Claims and Claims Adjustment Expense, Claims Paid 12 month
2026-06-30$1.32B
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$2.47B
10-Q · filed 2026-08-05
$4.25B
derived: sum of 3 quarters · filed 2026-08-05
$5.72B
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$1.15B
10-Q · filed 2026-05-06
$2.93B
derived: sum of 2 quarters · filed 2026-05-06
$4.40B
derived: sum of 3 quarters · filed 2026-05-06
$5.93B
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$1.78B
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$3.25B
derived: sum of 2 quarters · filed 2026-02-25
$4.78B
derived: sum of 3 quarters · filed 2026-08-05
$6.00B
10-K · filed 2026-02-25
2025-09-30$1.47B
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$3.00B
derived: sum of 2 quarters · filed 2026-08-05
$4.22B
10-Q · filed 2025-11-04
$6.00B
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$1.53B
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$2.75B
10-Q · filed 2026-08-05
$4.53B
derived: sum of 3 quarters · filed 2026-08-05
$5.94B
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$1.22B
10-Q · filed 2026-05-06
$3.00B
derived: sum of 2 quarters · filed 2026-05-06
$4.41B
derived: sum of 3 quarters · filed 2026-05-06
$5.96B
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$1.78B
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$3.19B
derived: sum of 2 quarters · filed 2026-02-25
$4.74B
derived: sum of 3 quarters · filed 2026-02-25
$5.65B
10-K · filed 2026-02-25
2024-09-30$1.41B
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$2.96B
derived: sum of 2 quarters · filed 2025-11-04
$3.87B
10-Q · filed 2025-11-04
$5.33B
derived: sum of 4 quarters · filed 2026-02-25
2024-06-30$1.54B
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04
$2.46B
10-Q · filed 2025-08-04
$3.92B
derived: sum of 3 quarters · filed 2026-02-25
$5.12B
derived: sum of 4 quarters · filed 2026-02-25
2024-03-31$912.03M
10-Q · filed 2025-05-06
$2.37B
derived: sum of 2 quarters · filed 2026-02-25
$3.57B
derived: sum of 3 quarters · filed 2026-02-25
$4.23B
derived: sum of 4 quarters · filed 2026-02-25
2023-12-31$1.46B
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$2.66B
derived: sum of 2 quarters · filed 2026-02-25
$3.32B
derived: sum of 3 quarters · filed 2026-02-25
$3.90B
10-K · filed 2026-02-25
2023-09-30$1.20B
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$1.85B
derived: sum of 2 quarters · filed 2024-11-07
$2.43B
10-Q · filed 2024-11-07
$3.21B
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30$655.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$1.23B
10-Q · filed 2024-08-06
$2.01B
derived: sum of 3 quarters · filed 2025-02-25
$2.60B
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31$579.05M
10-Q · filed 2024-05-07
$1.36B
derived: sum of 2 quarters · filed 2025-02-25
$1.94B
derived: sum of 3 quarters · filed 2025-02-25
2022-12-31$779.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
$1.37B
derived: sum of 2 quarters · filed 2025-02-25
$2.30B
10-K · filed 2025-02-25
2022-09-30$585.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
$1.52B
10-Q · filed 2023-11-02
2022-06-30$934.10M
10-Q · filed 2023-08-03
2021-12-31$1.57B
10-K · filed 2024-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Progyny, Inc. (PGNY)United States$1.994B28.37
VIEMED HEALTHCARE, INC. (VMD)United States$0.336B29.92
Park Dental Partners, Inc. (PARK)United States$0.094B
BioRestorative Therapies, Inc. (BRTX)United States$0.064B
CRYO CELL INTERNATIONAL INC (CCEL)United States$0.033B-11.02
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43
Sotera Health Co (SHC)United States$5.271B30.96
DAVITA INC. (DVA)United States$11.147B16.80